白塞综合征中AA淀粉样变性的发生率已下降:一项长期随访的回顾性研究及系统综述
该研究通过病历回顾分析了本中心白塞综合征(BS)队列中淀粉样变性患者的临床特征、治疗与结局,并按1976-2000年和2001-2017年两个注册时段分别估算AA淀粉样变性患病率,同时系统检索PubMed和EMBASE以汇总已报告的BS合并AA淀粉样变性病例。结果显示AA淀粉样变性患病率从早期队列的0.62%(24/3820)降至近期队列的0.054%(3/5590),系统综述共纳入42篇文献中的82例病例,患者以男性为主且血管受累频率高,三分之一患者在淀粉样变性诊断后6个月内死亡。
要点
- AA淀粉样变性患病率从1976-2000年注册队列的0.62%(24/3820)降至2001-2017年注册队列的0.054%(3/5590)。
- 系统综述纳入42篇文献共82例BS合并AA淀粉样变性病例,主要特征为男性为主和血管受累频率高。
- 三分之一患者在淀粉样变性诊断后6个月内死亡。
核心结论
- 白塞综合征患者中AA淀粉样变性的发生率已下降,与其他炎症性和感染性病因所致AA淀粉样变性的下降趋势相似。
- AA淀粉样变性是白塞综合征罕见但可能致命的并发症。
研究设计与样本
- 回顾性研究,通过病历回顾识别本中心白塞综合征队列中的淀粉样变性患者,并分析其临床和实验室特征、治疗及结局。
- 按1976-2000年和2001-2017年两个注册时段分别估算AA淀粉样变性患病率。
- 系统检索PubMed和EMBASE中关于白塞综合征合并AA淀粉样变性的报告,并使用GRADE工具评估偏倚风险。
- 主要终点为终末期肾病和死亡。
主要发现
- AA淀粉样变性患病率在早期队列(1976-2000年注册)为0.62%(24/3820),在近期队列(2001-2017年注册)降至0.054%(3/5590)。
- 系统综述共纳入42篇文献中的82例白塞综合征合并AA淀粉样变性病例。
- 这些患者的主要特征为男性为主和血管受累频率高。
- 三分之一患者在淀粉样变性诊断后6个月内死亡。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: A decline in the frequency of AA amyloidosis secondary to RA and infectious diseases has been reported. We aimed to determine the change in the frequency of AA amyloidosis in our Behçet's syndrome (BS) patients and to summarize the clinical characteristics of and outcomes for our patients, and also those identified by a systematic review. METHODS: We identified patients with amyloidosis in our BS cohort (as well as their clinical and laboratory features, treatment, and outcome) through a chart review. The primary end points were end-stage renal disease and death. The prevalence of AA amyloidosis was estimated separately for patients registered during 1976-2000 and those registered during 2001-2017, in order to determine whether there was any change in the frequency. We searched PubMed and EMBASE for reports on BS patients with AA amyloidosis. Risk of bias was assessed using the Grading of Recommendations Assessment, Development and Evaluation (GRADE) tool. RESULTS: The prevalence of AA amyloidosis was 0.62% (24/3820) in the earlier cohort and declined to 0.054% (3/5590) in the recent cohort. The systematic review revealed 82 cases in 42 publications. The main features of patients were male predominance and a high frequency of vascular involvement. One-third of patients died within 6 months after diagnosis of amyloidosis. CONCLUSION: The frequency of AA amyloidosis has decreased in patients with BS, which is similar to the decrease observed for AA amyloidosis due to other inflammatory and infectious causes. However, AA amyloidosis is a rare, but potentially fatal complication of BS.
引用
- Karatemiz G, Esatoglu SN, Gurcan M, et al. Frequency of AA amyloidosis has decreased in Behçet's syndrome: a retrospective study with long-term follow-up and a systematic review. Rheumatology (Oxford). 2022. PMID: 35657376. doi:10.1093/rheumatology/keac223
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。